Wealth Manager - the site for professional investment managers

Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

Barclays fined £26m over gold price fix

1 Comment
Barclays fined £26m over gold price fix

Barclays Bank faces a £26 million fine after regulators found the bank had failed to adequately manage conflicts of interest in daily gold price fixing over a period of almost 10 years.

The Financial Conduct Authority (FCA) also banned and fined former Barclays trader Daniel James Plunkett who ‘exploited the weaknesses’ in the company’s system to influence the price fixing.

His actions allowed the bank to avoid making a $3.9 million (£2.31 million) payment to a customer the FCA found, while boosting Plunkett’s trading book by $1.75 million.

‘A firm’s lack of controls and a trader’s disregard for a customer’s interests have allowed the financial services industry’s reputation to be sullied again,’ said FCA head of enforcement Tracey McDermott.   

‘Plunkett has paid a heavy price for putting his own interests above the integrity of the market and Barclays’ customer. Traders who might be tempted to exploit their clients for a quick buck should be in no doubt - such behaviour will cost you your reputation and your livelihood.’

The fine related from when Barclays joined the daily gold price fixing call in 2004 up to 2013.

Plunkett, who was a director on the bank’s precious metals desk, has been fined £95,600, in addition to being banned from regulated activity.

The FCA found that he had deliberately placed orders at the lower end of the bid spectrum in order to avoid having to pay out to a customer who held Barclays-issued gold option contracts.   

Both Barclays and Plunkett agreed to settle at an early stage and so qualified for a 30% discount on fines which would otherwise have totalled £37.19 million and £136,000 respectively.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Play Biotech Growth: we will ride out this storm

Biotech Growth: we will ride out this storm

Geoffrey Hsu of Biotech Growth Trust says the sell-off in biotechnology stocks represents a buying opportunity for long-term investors.

Play Picton: the UK property hotspots for rental income

Picton: the UK property hotspots for rental income

Picton Property Income CEO Michael Morris reveals how he is planning to ride the ‘ripple effect’ as UK economic growth spills out from the capital across the country.

Brewin's Foster talks financial crisis MkII with Allianz's Riddell

Brewin's Foster talks financial crisis MkII with Allianz's Riddell

This week Brewin Dolphin's head of research talks to Mike Riddell, fund manager at Allianz Global Investors, about the forces driving bonds markets in a tumultuous week for markets.

Your Business: Cover Star Club

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

In a buyers’ market for off-the-peg discretionary management, self-funded start-ups begin at an inherent disadvantage

Wealth Manager on Twitter